Tim Kaine actually said...

I am just troubled by the witnesses' unwillingness to offer professional opinions.

Drug pricing is a serious concern for everybody here and drug pricing of biologics is one of the matters that we are very concerned about.

So, as a general matter, reductions in NIH funding would have the effect of reducing innovation as a general matter?

Would a budget cut of that size to the NIH hurt the innovation that is one of the subjects of this hearing?